Concepedia

Daruka Mahadevan

DM

Statistics

Publications

6

Citations

139

H-Index

6

Active since

1990

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Daruka Mahadevan is an author at National Institutes of Health specializing in molecular biology, life sciences, and biochemistry.

Publications per year

1990–2025

6

Publications

6

Prediction of domain organisation and secondary structure of thyroid peroxidase, a human autoantigen involved in destructive thyroiditis

J. Paul Banga, Daruka Mahadevan, Geoffrey J. Barton et al. · FEBS Letters · 1990 · 38 citations

Life Sciences, Biochemistry, Molecular Biology +17

Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

Daruka Mahadevan, G. Sutton, Rafael Arteta-Bulos et al. · Cancer Chemotherapy and Pharmacology · 2014 · 37 citations

Medicine, Oncology, Pharmacology +13

β PDGFR‐IgG chimera demonstrates that human β PDGFR Ig‐like domains 1 to 3 are sufficient for high affinity PDGF BB binding

Mohammad A. Heidaran, Daruka Mahadevan, William J. LaRochelle · The FASEB Journal · 1995 · 24 citations

Life Sciences, Molecular Biology, Antibody Engineering +13

Comparison of calcium-dependent conformational changes in the N-terminal SH2 domains of p85 and gap defines distinct properties for SH2 domains

Daruka Mahadevan, Narmada Thanki, P McPhie et al. · Biochemistry · 1994 · 17 citations

Life Sciences, Biochemistry, Molecular Biology +17

First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies

Daruka Mahadevan, Minal Barve, Devalingam Mahalingam et al. · Journal of Hematology & Oncology · 2025 · 13 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 6